Cargando…

Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum

The purpose of this analysis was to evaluate if serum levels of potential tumor markers for the diagnosis of malignant mesothelioma and lung cancer are affected by confounding factors in a surveillance cohort of workers formerly exposed to asbestos. SMRP, CA125, and CYFRA21-1 concentrations were det...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Daniel Gilbert, Johnen, Georg, Taeger, Dirk, Weber, Anne, Gross, Isabelle Mercedes, Pesch, Beate, Kraus, Thomas, Brüning, Thomas, Gube, Monika
Formato: Texto
Lenguaje:English
Publicado: Libertas Academica 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814766/
https://www.ncbi.nlm.nih.gov/pubmed/20130785
_version_ 1782176994322022400
author Weber, Daniel Gilbert
Johnen, Georg
Taeger, Dirk
Weber, Anne
Gross, Isabelle Mercedes
Pesch, Beate
Kraus, Thomas
Brüning, Thomas
Gube, Monika
author_facet Weber, Daniel Gilbert
Johnen, Georg
Taeger, Dirk
Weber, Anne
Gross, Isabelle Mercedes
Pesch, Beate
Kraus, Thomas
Brüning, Thomas
Gube, Monika
author_sort Weber, Daniel Gilbert
collection PubMed
description The purpose of this analysis was to evaluate if serum levels of potential tumor markers for the diagnosis of malignant mesothelioma and lung cancer are affected by confounding factors in a surveillance cohort of workers formerly exposed to asbestos. SMRP, CA125, and CYFRA21-1 concentrations were determined in about 1,700 serum samples from 627 workers formerly exposed to asbestos. The impact of factors that could modify the concentrations of the tumor markers was examined with linear mixed models. SMRP values increased with age 1.02-fold (95% CI 1.01–1.03) and serum creatinine concentration 1.32-fold (95% CI 1.20–1.45). Levels differed by study centers and were higher after 40 years of asbestos exposure. CA125 levels increased with longer storage of the samples. CYFRA21-1 values correlated with age 1.02-fold (95% CI 1.01–1.02), serum creatinine 1.21-fold (95% CI 1.14–1.30) and varied by study centers due to differences in sample handling. Tumor marker concentrations are influenced by subject-related factors, sample handling, and storage. These factors need to be taken into account in screening routine.
format Text
id pubmed-2814766
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-28147662010-02-03 Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum Weber, Daniel Gilbert Johnen, Georg Taeger, Dirk Weber, Anne Gross, Isabelle Mercedes Pesch, Beate Kraus, Thomas Brüning, Thomas Gube, Monika Biomark Insights Original Research The purpose of this analysis was to evaluate if serum levels of potential tumor markers for the diagnosis of malignant mesothelioma and lung cancer are affected by confounding factors in a surveillance cohort of workers formerly exposed to asbestos. SMRP, CA125, and CYFRA21-1 concentrations were determined in about 1,700 serum samples from 627 workers formerly exposed to asbestos. The impact of factors that could modify the concentrations of the tumor markers was examined with linear mixed models. SMRP values increased with age 1.02-fold (95% CI 1.01–1.03) and serum creatinine concentration 1.32-fold (95% CI 1.20–1.45). Levels differed by study centers and were higher after 40 years of asbestos exposure. CA125 levels increased with longer storage of the samples. CYFRA21-1 values correlated with age 1.02-fold (95% CI 1.01–1.02), serum creatinine 1.21-fold (95% CI 1.14–1.30) and varied by study centers due to differences in sample handling. Tumor marker concentrations are influenced by subject-related factors, sample handling, and storage. These factors need to be taken into account in screening routine. Libertas Academica 2010-01-28 /pmc/articles/PMC2814766/ /pubmed/20130785 Text en © 2010 The authors. http://creativecommons.org/licenses/by/2.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/2.0/).
spellingShingle Original Research
Weber, Daniel Gilbert
Johnen, Georg
Taeger, Dirk
Weber, Anne
Gross, Isabelle Mercedes
Pesch, Beate
Kraus, Thomas
Brüning, Thomas
Gube, Monika
Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum
title Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum
title_full Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum
title_fullStr Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum
title_full_unstemmed Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum
title_short Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum
title_sort assessment of confounding factors affecting the tumor markers smrp, ca125, and cyfra21-1 in serum
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814766/
https://www.ncbi.nlm.nih.gov/pubmed/20130785
work_keys_str_mv AT weberdanielgilbert assessmentofconfoundingfactorsaffectingthetumormarkerssmrpca125andcyfra211inserum
AT johnengeorg assessmentofconfoundingfactorsaffectingthetumormarkerssmrpca125andcyfra211inserum
AT taegerdirk assessmentofconfoundingfactorsaffectingthetumormarkerssmrpca125andcyfra211inserum
AT weberanne assessmentofconfoundingfactorsaffectingthetumormarkerssmrpca125andcyfra211inserum
AT grossisabellemercedes assessmentofconfoundingfactorsaffectingthetumormarkerssmrpca125andcyfra211inserum
AT peschbeate assessmentofconfoundingfactorsaffectingthetumormarkerssmrpca125andcyfra211inserum
AT krausthomas assessmentofconfoundingfactorsaffectingthetumormarkerssmrpca125andcyfra211inserum
AT bruningthomas assessmentofconfoundingfactorsaffectingthetumormarkerssmrpca125andcyfra211inserum
AT gubemonika assessmentofconfoundingfactorsaffectingthetumormarkerssmrpca125andcyfra211inserum